An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy (Q47602512)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy |
scientific article |
Statements
1 reference
An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy (English)
1 reference
Ruoxin Zhang
Ming Jia
Yuan Xu
Danwen Qian
Mengyun Wang
Meiling Zhu
Menghong Sun
14 November 2017
1 reference